What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Cancer research, Cell biology, Gene, Molecular biology and Cancer.
His Cancer research research incorporates elements of Cisplatin, Mutation, Immunology, Poly Polymerase Inhibitor and Breast cancer.
Jos Jonkers has included themes like Replication fork protection, Regulation of gene expression, Receptor and Histone in his Cell biology study.
Gene is the subject of his research, which falls under Genetics.
His studies in Molecular biology integrate themes in fields like Transgene, Cre recombinase and DNA, DNA damage.
His biological study spans a wide range of topics, including Precision medicine, Pathology and Drug discovery.
His most cited work include:
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences (1082 citations)
- Patient-derived xenograft models: an emerging platform for translational cancer research. (839 citations)
- Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. (828 citations)
What are the main themes of his work throughout his whole career to date?
Jos Jonkers spends much of his time researching Cancer research, Breast cancer, Cancer, Carcinogenesis and Internal medicine.
The concepts of his Cancer research study are interwoven with issues in Olaparib, PARP inhibitor, Cisplatin, Immunology and DNA repair.
His work carried out in the field of PARP inhibitor brings together such families of science as Homologous recombination and Poly Polymerase Inhibitor.
His Breast cancer research includes themes of Metastasis and Pathology.
His Cancer study combines topics in areas such as Germline mutation, Gene and In vivo.
His study looks at the relationship between DNA damage and fields such as Molecular biology, as well as how they intersect with chemical problems.
He most often published in these fields:
- Cancer research (52.37%)
- Breast cancer (31.86%)
- Cancer (31.86%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (52.37%)
- Breast cancer (31.86%)
- Cancer (31.86%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Breast cancer, Cancer, Homologous recombination and PARP inhibitor.
The Cancer research study combines topics in areas such as DNA damage, Cancer cell, Poly ADP ribose polymerase, Gene and Genetic screen.
His Breast cancer study incorporates themes from Cadherin, PTEN, Cisplatin and In vivo.
His study in Cancer is interdisciplinary in nature, drawing from both Biobank and CRISPR.
His Homologous recombination study also includes
- Polymerase which connect with DNA repair,
- Cell biology and related Chromatin, Genome instability, CDH1 and Mammary tumor.
Jos Jonkers combines subjects such as Mutation, Germline mutation, BRCA mutation, Ovarian cancer and Olaparib with his study of PARP inhibitor.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- The Shieldin complex mediates 53BP1-dependent DNA repair (199 citations)
- Long-term expanding human airway organoids for disease modeling (188 citations)
In his most recent research, the most cited papers focused on:
Jos Jonkers spends much of his time researching Cancer research, PARP inhibitor, Breast cancer, Homologous recombination and Cell biology.
The study incorporates disciplines such as Cancer cell, Cancer, Genetically Engineered Mouse, DNA damage and Genetic screen in addition to Cancer research.
His PARP inhibitor research incorporates themes from Mutation, T cell, Olaparib and Tumor microenvironment.
His work deals with themes such as CRISPR, Carcinoma and Oncology, which intersect with Breast cancer.
His Homologous recombination research is multidisciplinary, incorporating elements of Polymerase, Poly ADP ribose polymerase and Mutant.
His studies deal with areas such as Immunity, DNA and Genome instability as well as Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
